Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Heffernan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Dermatology Online Journal|December 31, 2009
Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuationL Katie Morrison, James J Nordlund, Michael P Heffernan
Archives of Dermatology|June 22, 2005
Chronic cutaneous fusariosisJennifer M Gardner, Michael M Nelson, Michael P Heffernan
Archives of Dermatology|July 20, 2007
Painful nodule on the kneeMichael P Heffernan, Danette D Bentley, Beatriz Tapia, et al.
Journal of Drugs in Dermatology : JDD|August 4, 2010
Nephrogenic systemic fibrosis: a reviewAmy Y-Y Chen, Matthew J Zirwas, Michael P Heffernan
Journal of the American Academy of Dermatology|April 25, 2006
Efalizumab-induced subacute cutaneous lupus erythematosusDanette D Bentley, Julia E Graves, David I Smith, et al.
Archives of Dermatology|November 23, 2011
Pruritic scaly rash on arms and legsIlana S Rosman, Anne C Lind, Michael J Russell, et al.
Journal of the American Academy of Dermatology|July 18, 2006
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinibJulia E Graves, Beverly F Jones, Anne C Lind, et al.
Archives of Dermatology|September 21, 2005
0.1% tacrolimus ointment in the treatment of discoid lupus erythematosusMichael P Heffernan, Michael M Nelson, David I Smith, et al.
JAMA|March 17, 2006
Prevention of osteoporosis associated with chronic glucocorticoid therapyMichael P Heffernan, Kenneth G Saag, June K Robinson, et al.
Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Off-label uses of biologic agents in dermatology: a 2006 updateMary Jo J Kerns, Julia E Graves, David I Smith, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Dermatology Online Journal|December 31, 2009
Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuationL Katie Morrison, James J Nordlund, Michael P Heffernan
Archives of Dermatology|June 22, 2005
Chronic cutaneous fusariosisJennifer M Gardner, Michael M Nelson, Michael P Heffernan
Archives of Dermatology|July 20, 2007
Painful nodule on the kneeMichael P Heffernan, Danette D Bentley, Beatriz Tapia, et al.
Journal of Drugs in Dermatology : JDD|August 4, 2010
Nephrogenic systemic fibrosis: a reviewAmy Y-Y Chen, Matthew J Zirwas, Michael P Heffernan
Journal of the American Academy of Dermatology|April 25, 2006
Efalizumab-induced subacute cutaneous lupus erythematosusDanette D Bentley, Julia E Graves, David I Smith, et al.
Archives of Dermatology|November 23, 2011
Pruritic scaly rash on arms and legsIlana S Rosman, Anne C Lind, Michael J Russell, et al.
Journal of the American Academy of Dermatology|July 18, 2006
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinibJulia E Graves, Beverly F Jones, Anne C Lind, et al.
Archives of Dermatology|September 21, 2005
0.1% tacrolimus ointment in the treatment of discoid lupus erythematosusMichael P Heffernan, Michael M Nelson, David I Smith, et al.
JAMA|March 17, 2006
Prevention of osteoporosis associated with chronic glucocorticoid therapyMichael P Heffernan, Kenneth G Saag, June K Robinson, et al.
Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Off-label uses of biologic agents in dermatology: a 2006 updateMary Jo J Kerns, Julia E Graves, David I Smith, et al.
Pageof 4